Source: MarketScreener

Acacia Pharma: Acacia Pharma : Offer by Eagle - Scheme Document

(marketscreener.com) THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. PART II OF THIS DOCUMENT COMPRISES AN EXPLANATORY STATEMENT IN COMPLIANCE WITH SECTION 897 OF THE COMPANIES ACT 2006. This Document contains a proposal which, if implemented, will result in the cancellation of the listing and trading of Acacia...https://www.marketscreener.com/quote/stock/ACACIA-PHARMA-GROUP-PLC-41692449/news/Acacia-Pharma-Offer-by-Eagle-ndash-Scheme-Document-40165013/?utm_medium=RSS&utm_content=20220427

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Michael Bolinder's photo - CEO of Acacia Pharma

CEO

Michael Bolinder

CEO Approval Rating

90/100

Read more